These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 16368077

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.
    Aubry JM, Gervasoni N, Osiek C, Perret G, Rossier MF, Bertschy G, Bondolfi G.
    J Psychiatr Res; 2007; 41(3-4):290-4. PubMed ID: 16956623
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 6. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 7. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 8. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):409-15. PubMed ID: 19327969
    [Abstract] [Full Text] [Related]

  • 9. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder.
    Van Den Eede F, Van den Bossche B, Hulstijn W, Sabbe BG, Cosyns P, Claes SJ.
    J Affect Disord; 2006 Jul; 93(1-3):259-63. PubMed ID: 16677715
    [Abstract] [Full Text] [Related]

  • 10. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [Abstract] [Full Text] [Related]

  • 11. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 12. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.
    Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM.
    J Psychiatr Res; 2004 Oct; 38(6):553-7. PubMed ID: 15458850
    [Abstract] [Full Text] [Related]

  • 13. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    J Psychiatr Res; 2008 Apr; 42(5):356-64. PubMed ID: 17412362
    [Abstract] [Full Text] [Related]

  • 14. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):797-802. PubMed ID: 8750037
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity.
    Adli M, Bschor T, Bauer M, Lucka C, Lewitzka U, Ising M, Uhr M, Mueller-Oerlinghausen B, Baethge C.
    Neuropsychobiology; 2009 Dec 15; 60(1):23-30. PubMed ID: 19684420
    [Abstract] [Full Text] [Related]

  • 16. Trauma exposure in relation to basal salivary cortisol and the hormone response to the dexamethasone/CRH test in male railway employees without lifetime psychopathology.
    Klaassens ER, Giltay EJ, van Veen T, Veen G, Zitman FG.
    Psychoneuroendocrinology; 2010 Jul 15; 35(6):878-86. PubMed ID: 20036072
    [Abstract] [Full Text] [Related]

  • 17. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
    Schüle C, Zill P, Baghai TC, Eser D, Zwanzger P, Wenig N, Rupprecht R, Bondy B.
    Psychoneuroendocrinology; 2006 Sep 15; 31(8):1019-25. PubMed ID: 16890377
    [Abstract] [Full Text] [Related]

  • 18. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.
    Neuropsychobiology; 2007 Sep 15; 55(1):21-7. PubMed ID: 17556849
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.